As results from the report on development of the debts in health care system, new management of Ministry of Health plans to continue in decreasing of expenses on pharmaceuticals from the public health insurance. Planned measures involve the de-listing of supportive and supplementary pharmaceuticals from the reimbursement from health insurance and tightening of the rules of price-referencing of the pharmaceuticals. Ministry also expects savings due to creation of central purchasing unit. This unit will, based on the comparison of prices of all institutions in the scope of MoH, recommend the purchase price.